
Prominent Thoracic Surgeon to Lead New Division of Thoracic Surgery at UCSF
Key Takeaways
- UCSF established a standalone Thoracic Surgery Division, appointing Kratz as inaugural chief to steer clinical strategy, research direction, and surgical training within a high-volume academic robotic program.
- Robotic thoracic surgery expansion under Kratz has increased procedural volume and diversified service offerings, positioning UCSF as a regional leader in technology-enabled minimally invasive thoracic oncology.
Johannes R. Kratz, MD, has been named as the inaugural Chief of UCSF’s Division of Thoracic Surgery.
Johannes R. Kratz, MD, has been named as the inaugural Chief of UCSF’s Division of Thoracic Surgery, one of the leading, academic robotic thoracic surgery programs in the western United States. He brings a track record of innovation in surgical oncology and will guide multidisciplinary teams of surgeons, medical oncologists and radiation oncologists to provide state-of-the-art, comprehensive care to patients with a wide array of thoracic conditions. Kratz was appointed interim chief of the new division in July 2025 and assumes the role of chief on February 1, 2026.
Since 2023,
As chief of the
“I am confident that Johannes Kratz will continue his exceptional leadership, setting the direction for the future of thoracic care, research, and training in thoracic surgery,” said Julie Ann Sosa, MD, MA, FACS, the Leon Goldman, MD Distinguished Professor and Chair of the Department of Surgery at UCSF. “He is well suited to grow the division while refining surgical excellence and spurring innovation in the field.”
In addition to his clinical leadership, Kratz’s research has been productive and impactful. While a surgical research fellow at the UCSF Thoracic Oncology Laboratory, Kratz developed a test, now available to patients, that more accurately identifies early-stage lung cancer patients who benefit from adjuvant therapy. The Kratz Lab focuses on the genetic and immunological mechanisms that drive early-stage, surgically resectable thoracic malignancies, with the goal of identifying novel therapeutic targets and therapies for patients with early-stage, yet deadly thoracic malignancies.
Kratz earned his medical degree at Harvard Medical School and completed a general surgery residency at Massachusetts General Hospital, followed by a fellowship in cardiothoracic surgery at UCSF. He also holds a master's degree in philosophy from Stanford University.
Kratz is a member of the American College of Surgeons, American Association for Thoracic Surgery, Society of Thoracic Surgeons, and American Society of Clinical Oncology. He has published numerous papers and has been the recipient of many awards and honors including the UCSF Health Exceptional Physician Award, Cardiothoracic Surgery Faculty Teaching Award, Hellman Family Clinical-Translational Research Development Award, Michael DeBakey Research Scholarship, and Haile T. Debas Academy of Medical Educators Excellence in Teaching Award.



































